dr. ocean on impact of the prodige 24/cctg pa.6 trial in pancreatic cancer
Published 4 years ago • 228 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:30
#esmo21 highlights on gemcitabine vs mfolfirinox in resected pancreatic cancer: prodige 24/cctg pa6
-
1:10
dr. ocean discusses the use of ctdna in pancreatic cancer
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
-
3:35
cancer clinical trial: prodige 24/cctg pa.6
-
0:36
dr. ocean on the toxicities with sm-88 in metastatic pancreatic cancer
-
2:04
dr. ocean on efforts to improve early detection rates in pancreatic cancer
-
1:11
dr. ocean on the importance of vitamin d analogs in pancreatic cancer
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
1:46
prodige 24- adjuvant #gemcitabine versus modified folfirinox in resected #pancreaticcancer
-
1:52
dr. laber on the prodige 35-panoptimox trial in metastatic pancreatic cancer
-
1:53
dr. ulahannan on the prodige 35 trial in pancreatic cancer
-
4:14
pancreatic cancer - dr. allyson ocean
-
1:42
dr. bekaii-saab on the apact trial in pancreatic cancer
-
32:15
dr. ocean on combating the emotional toll caused by covid-19 in cancer
-
5:39
the napoli-1 trial in pancreatic cancer
-
1:17
dr. hochster on take-home message of the polo trial in pancreatic cancer
-
0:55
dr. chan on trial of cabozantinib in neuroendocrine tumors
-
1:59
dr. o’reilly on the utility of parp inhibitors in pancreatic cancer
-
1:17
dr. choti on the benefits of neoadjuvant chemotherapy in pancreatic cancer